My HPRA: Register

NULOJIX

250 Milligram Pdr/Conc/Soln for Infus

Bristol-Myers Squibb Pharma EEIGEU/1/11/694/001-002

Main Information

Trade NameNULOJIX
Active SubstancesBELATACEPT
Strength250 Milligram
Dosage FormPdr/Conc/Soln for Infus
Licence HolderBristol-Myers Squibb Pharma EEIG
Licence NumberEU/1/11/694/001-002

Group Information

ATC CodeL04AA28 Selective immunosuppressants

Status

Authorised/WithdrawnAuthorised
Licence Issued17/06/2011
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Educational Materials - Patient

Enclosed in medication pack with package leaflet
« Back
Follow medicine

Print